Welcome
Support Centre
03 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
The effect of patient education on compliance with drug therapy for rheumatoid arthritis
ISRCTN ISRCTN68585617
ClinicalTrials.gov identifier
Public title The effect of patient education on compliance with drug therapy for rheumatoid arthritis
Scientific title
Acronym N/A
Serial number at source B0508
Study hypothesis Treatment of rheumatoid arthritis (RA) by disease-modifying drugs in which dosage is not symptom driven, is subject to substantial variation in compliance. Our previous work, using a novel pharmacological 'gold standard' for the measurement of compliance in which D-penicillamine was labelled with a homeopathic dose of phenobarbitone, showed that 42% of patients failed to follow instructions of dosage. It is proposed to use the same objective technique, validated clinical measures and a proven knowledge questionnaire, to investigate the effect on compliance of two different levels of patient education amongst RA patients.
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Rheumatoid arthritis
Participants - inclusion criteria 1. All patients deemed by the consultant rheumatologist to require dPenicillamine (DPA) as their disease modifying anti-rheumatic drug (DMARD)
2. Over 18 years of age
3. Plasma Viscosity (PV) ≤1.75
4. Cysteine rich protein (CRP) ≤10
5. Articular index 15 or less than
6. Morning stiffness ≤45 min
7. Pain level moderate/severe
Participants - exclusion criteria Does not meet inclusion criteria
Anticipated start date 12/01/1993
Anticipated end date 31/08/1998
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions Experimental group received a patient education programme
Primary outcome measure(s) It is anticipated that effective education will enhance compliance leading to better drug utilisation and improved patient outcome.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Arthritis Research Campaign (ARC) (UK)
Trial website
Publications 2001 results in http://www.ncbi.nlm.nih.gov/pubmed/11502614
Contact name Ms  Jackie  Hill
  Address CPU (Rheumatism Research)
University of Leeds
Chapel Allerton Hospital
Harehills Lane
  City/town Leeds
  Zip/Postcode LS7 4SA
  Country United Kingdom
  Tel +44 (0)113 262 3404
  Email j.hill@leeds.ac.uk
Sponsor Arthritis Research Campaign (ARC) (UK)
  Address Copeman House
St Mary's Court
St Mary's Gate
Chesterfield
  City/town Derbyshire
  Zip/Postcode S41 7TD
  Country United Kingdom
  Email info@arc.org.uk
  Sponsor website: http://www.arc.org.uk
Date applied 30/07/2002
Last edited 09/09/2009
Date ISRCTN assigned 30/07/2002
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central